Middle East And Asia Pacific Antibody Drugs Market
Antibody drugs are established first-line treatment modalities for a range of cancer and other diseases. On the basis of type, the Middle East and Asia Pacific antibody drugs market is segmented into Monoclonal Antibody, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody.
Monoclonal Antibody are laboratory-produced antibodies designed to recognize and bind to specific receptors found on the surface of cells. Monoclonal Antibody are used in the diagnosis and treatment of various diseases including some types of cancer. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Biosimilar Monoclonal Antibody (mAbs) are part of the biosimilar family. They are large, complex proteins used by the immune system to identify and neutralize foreign bodies such as bacteria, viruses, and others, and are usually administered in the treatment of diseases such as cancer or rheumatoid arthritis.
Market Dynamics
The high prevalence of chronic diseases such as cancer, multiple sclerosis, asthma, rheumatoid arthritis, psoriasis, and others is expected to drive the Middle East and Asia Pacific antibody drugs market growth in the forecast period. For instance, according to the Cancer Country Profile 2020 published by the World Health Organization (WHO), the total number of cancer cases in 2018 in Bahrain was 1,048 with 603 deaths. Moreover, as per the information provided in an article published in the Journal of Clinical Medicine in 2021, Saudi Arabia has the highest prevalence of non-communicable diseases (NCDs) such as cancer, cardiovascular disease, and others, which account for 73% of the country's mortality.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Detailed Segmentation:
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
